Moderna (MRNA) Stock Up 10%, It Set to Benefit from COVID-19 Vaccine and Increased Testing

Coinspeaker
Moderna (MRNA) Stock Up 10%, It Set to Benefit from COVID-19 Vaccine and Increased Testing

Moderna (MRNA) stock is one of the biotech firms taking the lead in the current fight against COVID-19. The company could see fortunes change soon. Yesterday, MRNA gained over 10%, today in the pre-market, it is up another 3.89%.

Moderna (MRNA) Stock Up 10%, It Set to Benefit from COVID-19 Vaccine and Increased Testing

Coinspeaker

37 total views, 1 views today

Author: toutiao